Is it better to take Sotolaxib (AMG 510) before or after meals for better absorption?
Sotorasib is an oral KRAS G12C inhibitor, mainly used to treat patients with advanced non-small cell lung cancer carrying KRAS G12C mutations. The correct time and method of taking medication is crucial for drug absorption and effectiveness. Studies have shown that the absorption rate and bioavailability of sotorasibu are affected by the gastric environment and feeding state, but in general, its oral absorption is relatively stable and can be taken on an empty stomach or with food.
In clinical practice, it is usually recommended to take sotoraxib at a fixed time every day to maintain stable blood concentration. Although the drug instructions do not strictly limit taking before or after meals, some studies have shown that taking after meals may slightly delay the absorption time compared with fasting, but does not significantly affect the overall drug exposure (AUC). Therefore, patients can choose to take it before or after meals according to their own living habits, while ensuring the consistency of daily medication time to stabilize the drug concentration in the body.

It should be noted that if the patient also has digestive system discomfort, such as hyperacidity or stomach discomfort, it is recommended to take it with or after a meal to reduce gastrointestinal irritation. Sotoracib may cause mild nausea, diarrhea or indigestion, which can be alleviated to a certain extent by taking it after meals, thereby improving patient tolerance and medication compliance.
Overall, the efficacy of sotoraxib is not significantly affected whether it is taken before or after meals. The key is to take the medicine regularly at a fixed time every day and make individual adjustments based on the doctor's advice. Patients should closely observe their own reactions during use. If severe gastrointestinal discomfort or other side effects occur, they should promptly report to the doctor and adjust the medication method or time according to the doctor's instructions to ensure drug efficacy and safety.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)